Zhengye Biotechnology Holding (ZYBT) Receivables - Net (2023 - 2024)
Zhengye Biotechnology Holding (ZYBT) has disclosed Receivables - Net for 2 consecutive years, with $10.6 million as the latest value for Q4 2024.
- Quarterly Receivables - Net rose 3.31% to $10.6 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $10.6 million through Dec 2024, up 3.31% year-over-year, with the annual reading at $8.2 million for FY2024, 22.25% down from the prior year.
- Receivables - Net for Q4 2024 was $10.6 million at Zhengye Biotechnology Holding, up from $10.3 million in the prior quarter.
- The five-year high for Receivables - Net was $10.6 million in Q4 2024, with the low at $10.3 million in Q4 2023.